News

Published on 31 Aug 2022 on Benzinga via Yahoo Finance

EXCLUSIVE: Longeveron's Lomecel-B Product Gets US FDA Fast Track Designation For Treatment Of...

Article preview image

The U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to Longeveron Inc (NASDAQ: LGVN) Lomecel-B for the treatment of Hypoplastic Left Heart Syndrome (HLHS).

HLHS is a rare and life-threatening congenital heart defect affecting approximately 1,000 infants per year.

Read the rest of the article
NASDAQ.LGVN price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday’s...

Shares of The Travelers Companies, Inc. TRV fell sharply during Wednesday’s session following fi...

Benzinga 17 Apr 2024
Longeveron to raise $6.2 million through warrant exercises By Investing.com

Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company, announced today that it h...

Investing.com 17 Apr 2024
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.65% By Investing.com

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.65%

Investing.com 15 Apr 2024
Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In...

Shares of Ultragenyx Pharmaceutical Inc. RARE fell sharply during Monday’s session after the co...

Benzinga 15 Apr 2024
Dow Jumps Over 300 Points; Goldman Sachs Posts Upbeat Earnings -Longeveron (NASDAQ:LGVN), Goldman...

U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 300 points on ...

Benzinga 15 Apr 2024
Why Medical Properties Trust Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving...

Shares of Medical Properties Trust, Inc. MPW rose sharply in today’s pre-market trading after th...

Benzinga 15 Apr 2024
Chief Scientific Officer Joshua Hare Acquires 148,936 Shares of Longeveron Inc (LGVN)

Longeveron Inc (NASDAQ:LGVN), a biotechnology company specializing in the development of cellular...

GuruFocus.com via Yahoo Finance 12 Apr 2024
Longeveron director buys $325,000 in company stock By Investing.com

Longeveron Inc. (NASDAQ:LGVN) director Soffer Rock has recently made significant purchases of the...

Investing.com 12 Apr 2024
Longeveron CEO buys $25k in company stock

Longeveron Inc. (NASDAQ:LGVN) CEO Hashad Mohamed Wa'el Ahmed acquired additional shares in the co...

Investing.com 11 Apr 2024
US Stocks Higher; Dow Gains Over 50 Points - Ducommun (NYSE:DCO), Auddia (NASDAQ:AUUD)

U.S. stocks traded higher this morning, with the Dow Jones index gaining over 50 points on Monday...

Benzinga 8 Apr 2024

Copyright Statfolio @ 2024

Social Accounts